Harbour Investments’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$88 Hold
50
﹤0.01% 4520
2025
Q4
$118 Hold
50
﹤0.01% 3727
2025
Q3
$153 Hold
50
﹤0.01% 3612
2025
Q2
$140 Hold
50
﹤0.01% 3496
2025
Q1
$180 Sell
50
-25
-33% -$100 ﹤0.01% 3432
2024
Q4
$236 Hold
75
﹤0.01% 3357
2024
Q3
$212 Hold
75
﹤0.01% 3271
2024
Q2
$92 Hold
75
﹤0.01% 3213
2024
Q1
$60 Hold
75
﹤0.01% 3167
2023
Q4
$71 Hold
75
﹤0.01% 3071
2023
Q3
$81 Hold
75
﹤0.01% 2937
2023
Q2
$67 Hold
75
﹤0.01% 2974
2023
Q1
$63 Hold
75
﹤0.01% 2947
2022
Q4
$70 Sell
75
-125
-63% -$167 ﹤0.01% 2942
2022
Q3
$0 Hold
200
﹤0.01% 2731
2022
Q2
$0 Buy
+200
New +$532 ﹤0.01% 2731
2021
Q4
$1K Sell
175
-780
-82% -$4.78K ﹤0.01% 2485
2021
Q3
$7K Buy
955
+755
+378% +$6.46K ﹤0.01% 2820
2021
Q2
$3K Buy
200
+50
+33% +$491 ﹤0.01% 3219
2021
Q1
$1K Buy
+150
New +$1.69K ﹤0.01% 3338

Other funds holding CLOV

Harbour Investments's CLOV Position: Q1 2026 in Review

Harbour Investments held its Clover Health Investments (CLOV) position steady in Q1 2026 at 50 shares worth $88. The position accounts for ﹤0.01% of the portfolio, ranked #4520.

Harbour Investments first reported a position in CLOV in Q1 2021 and has held it in 20 quarters since. The position peaked at $7K in Q3 2021. 208 funds tracked by Wall St. Rank hold CLOV as of Q1 2026.

  • Harbour Investments held 50 shares of Clover Health Investments worth $88 as of Q1 2026.
  • Harbour Investments left its Clover Health Investments share count unchanged in Q1 2026.
  • Clover Health Investments made up ﹤0.01% of Harbour Investments's portfolio in Q1 2026, its #4520 holding.
  • Harbour Investments first reported a position in Clover Health Investments in Q1 2021 and has held it in 20 quarters since.
  • Harbour Investments's Clover Health Investments position peaked at $7K in Q3 2021.
  • 208 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.